Patents by Inventor Chau-Zen Wang

Chau-Zen Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING OR ALLEVIATING BONE-LOSS RELATED DISEASE OR CONDITION
    Publication number: 20210162074
    Abstract: The present invention relates to a method for treating or alleviating an osteoporosis in a subject. The method comprises steps of identifying the subject having the osteoporosis, and administering to the subject an effective amount of a composition that increases a level of Discoidin Domain Receptor 1 (DDR1) protein in the subject.
    Type: Application
    Filed: February 5, 2021
    Publication date: June 3, 2021
    Applicant: Kaohsiung Medical University
    Inventors: Chau-Zen Wang, Chung-Hwan Chen, Liang-Yin Chou, Yu Chou, Mei-Ling Ho, Yi-Hsiung Lin
  • Methods of treating or alleviating joint diseases by administering an inhibitor of discoidin domain receptor 1 (DDR1)
    Patent number: 10946021
    Abstract: The present invention relates to a use of Discoidin Domain Receptor 1 (DDR1) inhibitor in preparing a medicament for preventing or treating a joint disease. The present invention further relates to a use of DDR1 activator in preparing a medicament for preventing or treating abnormalities of endochondral ossification-related conditions.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: March 16, 2021
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Chau-Zen Wang, Chung-Hwan Chen, Liang-Yin Chou, Yu Chou, Mei-Ling Ho, Yi-Hsiung Lin
  • INHIBITOR AND ACTIVATOR OF DISCOIDIN DOMAIN RECEPTOR 1 AND THEIR USE
    Publication number: 20200030332
    Abstract: The present invention relates to a use of Discoidin Domain Receptor 1 (DDR1) inhibitor in preparing a medicament for preventing or treating a joint disease. The present invention further relates to a use of DDR1 activator in preparing a medicament for preventing or treating abnormalities of endochondral ossification-related conditions.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 30, 2020
    Applicant: Kaohsiung Medical University
    Inventors: Chau-Zen Wang, Chung-Hwan Chen, Liang-Yin Chou, Yu Chou, Mei-Ling Ho, Yi-Hsiung Lin
  • HYALURONIC ACID HYDROGEL AND USE THEREOF
    Publication number: 20130171197
    Abstract: The present invention provides a hydrogel comprising a poly(N-isopropylacrylamide) cross-linked hyaluronic acid. The present invention also provides a method of synthesizing a hydrogel comprising poly(N-isopropylacrylamide) cross-linked hyaluronic acid, which comprises (a) synthesizing methacrylated hyaluronic acid; and (b) copolymerizing methacrylated hyaluronic acid with N-isopropylacrylamide.
    Type: Application
    Filed: December 28, 2011
    Publication date: July 4, 2013
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Mei-Ling Ho, Rajalakshmanan Eswaramoorthy, Shun-Cheng Wu, Gwo-Jaw Wang, Je-Ken Chang, Yin-Chih Fu, Cherng-Chyi Tzeng, Chau-Zen Wang